Chemokinostatin-7

General Information


DRACP ID  DRACP02513

Peptide Name   Chemokinostatin-7

Sequence  DGRKICLDPDAPRIKKIVQKKL

Sequence Length  22

UniProt ID  P02775 

PubChem CID  Not available

Origin  Homo sapiens (CXCL7/PBP)

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides Antiangiogenic



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  CXCR

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02513

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C112H200N34O30S

Absent amino acids  EFHMNSTWY

Common amino acids  K

Mass  290987

Pl  10.62

Basic residues  7

Acidic residues  3

Hydrophobic residues  7

Net charge  4

Boman Index  -5662

Hydrophobicity  -75

Aliphatic Index  106.36

Half Life 
  Mammalian: 1.4 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18307172

Title  Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines

Doi 10.1002/jcb.21712

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.